E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/22/2005 in the Prospect News Biotech Daily.

Minrad obtains $3.5 million revolver

By E. Janene Geiss

Philadelphia, Dec. 22 - Minrad Inc. said it obtained a $3.5 million revolving line of credit from KeyBank NA and plans to use it for working capital, for corporate development and to refinance existing debt.

The line of credit has a term of one year based on the percentage of eligible inventory and receivables.

Minrad is a Buffalo, N.Y., pharmaceutical company focused on interventional pain management.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.